메뉴 건너뛰기




Volumn 7, Issue 43, 2016, Pages 69760-69769

Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation

Author keywords

DFG in c Helix out; EGFR kinase; Ibrutinib; Inactive conformation; NSCLC

Indexed keywords

ARGININE; CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; IBRUTINIB; LAPATINIB; LEUCINE; METHIONINE; N [3 [[5 CHLORO 2 [[2 METHOXY 4 (4 METHYL 1 PIPERAZINYL)PHENYL]AMINO] 4 PYRIMIDINYL]OXY]PHENYL]ACRYLAMIDE; NERATINIB; OSIMERTINIB; ROCILETINIB; THREONINE; ACRYLAMIDE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

EID: 84994230246     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11951     Document Type: Article
Times cited : (36)

References (27)
  • 2
    • 84897055483 scopus 로고    scopus 로고
    • Targeting Bruton's tyrosine kinase in B cell malignancies
    • Hendriks RW, Yuvaraj S, Kil LP. Targeting Bruton's tyrosine kinase in B cell malignancies. Nat Rev Cancer. 2014; 14:219-232.
    • (2014) Nat Rev Cancer , vol.14 , pp. 219-232
    • Hendriks, R.W.1    Yuvaraj, S.2    Kil, L.P.3
  • 5
    • 84910071839 scopus 로고    scopus 로고
    • Ibrutinib for the treatment of mantle cell lymphoma
    • Herrera AF, Jacobsen ED. Ibrutinib for the treatment of mantle cell lymphoma. Clin Cancer Res. 2014; 20:5365-5371.
    • (2014) Clin Cancer Res , vol.20 , pp. 5365-5371
    • Herrera, A.F.1    Jacobsen, E.D.2
  • 7
    • 84922787400 scopus 로고    scopus 로고
    • Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT, BCL2 pathways
    • Zhao X, Bodo J, Sun D, Durkin L, Lin J, Smith MR, Hsi ED. Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT, BCL2 pathways. Br J Haematol. 2015; 168:765-768.
    • (2015) Br J Haematol , vol.168 , pp. 765-768
    • Zhao, X.1    Bodo, J.2    Sun, D.3    Durkin, L.4    Lin, J.5    Smith, M.R.6    Hsi, E.D.7
  • 8
    • 84897853580 scopus 로고    scopus 로고
    • Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
    • Rushworth SA, Murray MY, Zaitseva L, Bowles KM, MacEwan DJ. Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood. 2014; 123:1229-1238.
    • (2014) Blood , vol.123 , pp. 1229-1238
    • Rushworth, S.A.1    Murray, M.Y.2    Zaitseva, L.3    Bowles, K.M.4    MacEwan, D.J.5
  • 9
    • 84867589196 scopus 로고    scopus 로고
    • BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-kappaB
    • Rushworth SA, Bowles KM, Barrera LN, Murray MY, Zaitseva L, MacEwan DJ. BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-kappaB. Cell Signal. 2013; 25:106-112.
    • (2013) Cell Signal , vol.25 , pp. 106-112
    • Rushworth, S.A.1    Bowles, K.M.2    Barrera, L.N.3    Murray, M.Y.4    Zaitseva, L.5    MacEwan, D.J.6
  • 13
    • 19744364796 scopus 로고    scopus 로고
    • Structural bioinformatics-based design of selective, irreversible kinase inhibitors
    • Cohen MS, Zhang C, Shokat KM, Taunton J. Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science. 2005; 308:1318-1321.
    • (2005) Science , vol.308 , pp. 1318-1321
    • Cohen, M.S.1    Zhang, C.2    Shokat, K.M.3    Taunton, J.4
  • 16
    • 33745002702 scopus 로고    scopus 로고
    • An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
    • Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell. 2006; 125:1137-1149.
    • (2006) Cell , vol.125 , pp. 1137-1149
    • Zhang, X.1    Gureasko, J.2    Shen, K.3    Cole, P.A.4    Kuriyan, J.5
  • 20
    • 84922753595 scopus 로고    scopus 로고
    • Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer
    • Yap TA, Popat S. Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer. Pharmgenomics Pers Med. 2014; 7:285-295.
    • (2014) Pharmgenomics Pers Med , vol.7 , pp. 285-295
    • Yap, T.A.1    Popat, S.2
  • 22
    • 33745933955 scopus 로고    scopus 로고
    • HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes
    • Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr. 2006; 62:859-866.
    • (2006) Acta Crystallogr D Biol Crystallogr , vol.62 , pp. 859-866
    • Minor, W.1    Cymborowski, M.2    Otwinowski, Z.3    Chruszcz, M.4
  • 27
    • 7544226311 scopus 로고    scopus 로고
    • PRODRG: a tool for high-throughput crystallography of protein-ligand complexes
    • Schuttelkopf AW and van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60:1355-1363.
    • (2004) Acta Crystallogr D Biol Crystallogr , vol.60 , pp. 1355-1363
    • Schuttelkopf, A.W.1    van Aalten, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.